 guidance surrounding the
dynamic target of optimal medical management for arterial disease.
Antiplatelet Therapy
 ASA offers a 22% risk reduction in major vascular events with no difference in protection
based on dosage (81 versus 325 mg).
 Clopidogrel can be used as an adjunct or alternative to ASA, but the added benefit from
dual antiplatelet combination in asymptomatic carotid artery stenosis is unproven.
Anticoagulants
 Only